Mitochondrial Genome Variations Linked to Esophageal Cancer

Strategic Insights -

Research conducted at the Affiliated Hospital of North Sichuan Medical College in the People's Republic of China has shed light on the association between mitochondrial genome variations and the development of esophageal cancer. The study, which aimed to explore the distribution and pathogenicity of mitochondrial genome variations in esophageal cancer, found that patients with the disease exhibited a higher frequency of variants in genes such as ND2, COX1, COX2, 12S rRNA, and 16S rRNA compared to healthy controls. Notably, the study identified several potentially pathogenic variants and suggested that haplogroup D4 may be a protective haplogroup against the development of esophageal cancer.

Key Takeaways:

  • The study identified 1299 mitochondrial variants among 146 esophageal cancer patients, including 171 novel mutations.
  • Compared to healthy controls, the esophageal cancer cohort exhibited a higher frequency of variants in genes such as ND2, COX1, COX2, 12S rRNA, and 16S rRNA.
  • Three tRNA mutations (7496_T C, 5771_A G, and 5613_T A) were predicted to be potentially pathogenic.
  • Within the protein-coding regions, 14 variants were classified as deleterious based on predictions from 13 independent bioinformatic algorithms.
  • Mitochondrial haplogroup D4 was significantly associated with a decreased risk of developing esophageal cancer.
  • Several mtDNA single-nucleotide polymorphisms (SNPs), including 302_A AC, 1824_T C, 1842_A G, 3010_G A, 8414_C T, and 14668_C T, showed significant associations with EC susceptibility.
  • The number of variations in multiple regions of the mitochondrial genome in the EC population was higher than that in the control group.

Statistics:

  • 1299 mitochondrial variants were identified among 146 esophageal cancer patients.
  • 171 novel mutations were identified among the 1299 mitochondrial variants.
  • 14 variants were classified as deleterious based on predictions from 13 independent bioinformatic algorithms.
  • 3 tRNA mutations (7496_T C, 5771_A G, and 5613_T A) were predicted to be potentially pathogenic.
  • 122 samples were used as healthy controls in the study.

Sources:

  • "Next-generation sequencing of mitochondrial DNA reveals pathogenic variants and protective haplogroup D4 in esophageal cancer." Frontiers in Genetics, 2025;16:1643229.
  • Affiliated Hospital of North Sichuan Medical College
  • Institute of Basic Medicine and Forensic Medicine, North Sichuan Medical College and Center for Genetics and Prenatal Diagnosis, Affiliated Hospital of North Sichuan Medical College
  • Frontiers Media Sa, Avenue Du Tribunal Federal 34, Lausanne, Ch-1015, Switzerland.